New GMFH “best of” document highlights the latest research on the gut barrier
Western diets high in fats and sugars, modern lifestyles with stress and sedentarism and the indiscriminate use of antibiotics together with other frequently prescribed drugs -such as non-steroidal anti-inflammatory drugs and proton pump inhibitors- are major drivers of changes in microbiota composition and gut barrier disruption. (Dr. Maria Rescigno)
The GMFH publishing team is pleased to share a new summary document—this one on the latest scientific work on the intestinal barrier. With an editorial from Dr. Maria Rescigno, Professor at Humanitas University and group leader at Humanitas Research hospital of Milan (Italy), this document contains a selection of key scientific studies related to the intestinal barrier, plus a list of resources for further reading.
The GMFH team will continue to keep you updated on this exciting topic—check our website regularly or subscribe to our twice-monthly newsletter!
“Best of” document on Gut Barrier
GMFH Editing Team
GMFH Editing Team
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.